NICE has published draft guidance recommending AstraZeneca’s anti-clotting drug Brilique (ticagrelor 60 mg) with aspirin for people who have had a heart attack. A higher 90mg dose of the drug is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback